These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28709456)

  • 1. Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation.
    Zhao L; Shen Y; Guo JD; Gu HL; Yu W; Wang JM; Lv CX; Liu J; Cai XW; Fu XL
    Radiat Oncol; 2017 Jul; 12(1):118. PubMed ID: 28709456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial metastatic disease spares the limbic circuit: a review of 697 metastatic lesions in 107 patients.
    Marsh JC; Herskovic AM; Gielda BT; Hughes FF; Hoeppner T; Turian J; Abrams RA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):504-12. PubMed ID: 20117288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications for preserving neural stem cells in whole brain radiotherapy and prophylactic cranial irradiation: a review of 2270 metastases in 488 patients.
    Wan JF; Zhang SJ; Wang L; Zhao KL
    J Radiat Res; 2013 Mar; 54(2):285-91. PubMed ID: 23022606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
    J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hippocampal metastases in small cell lung cancer patients at presentation and after cranial irradiation: a safety profile study for hippocampal sparing during prophylactic or therapeutic cranial irradiation.
    Kundapur V; Ellchuk T; Ahmed S; Gondi V
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):781-6. PubMed ID: 25752392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer.
    Qu XM; Mishra MV; Bauman GS; Slotman B; Mehta M; Gondi V; Louie AV
    Radiother Oncol; 2017 Mar; 122(3):411-415. PubMed ID: 28109544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
    Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
    Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Hippocampal Avoidance During Whole-Brain Radiotherapy Risky for Patients With Small-Cell Lung Cancer? Hippocampal Metastasis Rate and Associated Risk Factors.
    Korkmaz Kirakli E; Oztekin O
    Technol Cancer Res Treat; 2017 Dec; 16(6):1202-1208. PubMed ID: 29332467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
    Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
    Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?
    Sio TT; Prayongrat A; Zhang Y; Lin Q; Xu T; Liao Z; Yue J
    Clin Lung Cancer; 2018 Jul; 19(4):289-293. PubMed ID: 29665993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Present role of prophylactic cranial irradiation].
    Le Péchoux C; Al Mohkles H; Dhermain F
    Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
    Sharma S; McMillan MT; Doucette A; Cohen RB; Berman A; Levin W; Simone CB; Shabason J
    Clin Lung Cancer; 2018 May; 19(3):260-269.e3. PubMed ID: 29358031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should all patients with SCLC receive prophylactic cranial irradiation if they have responded to treatment? PCI should be offered in nearly all cases.
    Slotman BJ
    Clin Adv Hematol Oncol; 2015 Nov; 13(11):729-31. PubMed ID: 27058696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
    Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH
    JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of intracranial failure risk following hippocampal-sparing whole brain radiotherapy.
    Harth S; Abo-Madyan Y; Zheng L; Siebenlist K; Herskind C; Wenz F; Giordano FA
    Radiother Oncol; 2013 Oct; 109(1):152-8. PubMed ID: 24100152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early versus late prophylactic cranial irradiation in patients with extensive small cell lung cancer.
    Chen Y; Li J; Zhang Y; Hu Y; Zhang G; Yan X; Lin Z; Zhao Z; Jiao S
    Strahlenther Onkol; 2018 Oct; 194(10):876-885. PubMed ID: 29774395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of reducing the irradiation dose in regions of active neurogenesis for prophylactic cranial irradiation in patients with small-cell lung cancer.
    Tarnawski R; Michalecki L; Blamek S; Hawrylewicz L; Piotrowski T; Slosarek K; Kulik R; Bobek-Billewicz B
    Neoplasma; 2011; 58(6):507-15. PubMed ID: 21895404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation.
    Bartel F; van Herk M; Vrenken H; Vandaele F; Sunaert S; de Jaeger K; Dollekamp NJ; Carbaat C; Lamers E; Dieleman EMT; Lievens Y; de Ruysscher D; Schagen SB; de Ruiter MB; de Munck JC; Belderbos J
    Clin Transl Oncol; 2019 Feb; 21(2):178-186. PubMed ID: 29876759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.